Follow the people · Insider
Bobak R. Azamian
Bobak R. Azamian files insider transactions with the SEC as a president/ceo and board chair of Tarsus Pharmaceuticals (TARS). We hold 5 disclosed purchases and sales filed since 20 October 2020, 2 of them in the last 90 days.
- Files forTARS
- Disclosed buys and sells5 in all, 2 in the last 90 days
- Last disclosure3 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 20 October 2020 — 2 September 2026President/CEO and Board Chair · Tarsus Pharmaceuticals (TARS)126 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 10,000 shares of Tarsus PharmaceuticalsSEC Form 43 September 2026Common Stock · traded 2 September 2026 · filed 3 September 2026
- ▼ sold on the open market 4,582 shares of Tarsus PharmaceuticalsSEC Form 422 June 2026Common Stock · traded 17 June 2026 · filed 22 June 2026
- ▼ sold on the open market 5,418 shares of Tarsus PharmaceuticalsSEC Form 422 June 2026Common Stock · traded 17 June 2026 · filed 22 June 2026
- ▼ sold on the open market 10,972 shares of Tarsus PharmaceuticalsSEC Form 419 March 2026Common Stock · traded 17 March 2026 · filed 19 March 2026
- ▼ sold on the open market 11,667 shares of Tarsus PharmaceuticalsSEC Form 419 March 2026Common Stock · traded 18 March 2026 · filed 19 March 2026
- ▼ sold on the open market 11,964 shares of Tarsus PharmaceuticalsSEC Form 419 March 2026Common Stock · traded 19 March 2026 · filed 19 March 2026
- ▼ sold on the open market 10,972 shares of Tarsus PharmaceuticalsSEC Form 419 March 2026Common Stock · traded 17 March 2026 · filed 19 March 2026
- ▼ sold on the open market 11,667 shares of Tarsus PharmaceuticalsSEC Form 419 March 2026Common Stock · traded 18 March 2026 · filed 19 March 2026
- ▼ sold on the open market 11,964 shares of Tarsus PharmaceuticalsSEC Form 419 March 2026Common Stock · traded 19 March 2026 · filed 19 March 2026
- exercised options over 66,274 shares of Tarsus PharmaceuticalsSEC Form 417 March 2026Common Stock · traded 15 March 2026 · filed 17 March 2026
- exercised options over 11,300 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 417 March 2026Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 16,975 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 417 March 2026Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 11,300 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 417 March 2026Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 16,975 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 417 March 2026Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 23,121 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 417 March 2026Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 14,878 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 417 March 2026Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 23,121 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 417 March 2026Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 14,878 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 417 March 2026Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 66,274 shares of Tarsus PharmaceuticalsSEC Form 417 March 2026Common Stock · traded 15 March 2026 · filed 17 March 2026
- was granted 96,723 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 49 March 2026Stock Option (right to buy) · traded 5 March 2026 · filed 9 March 2026
- was granted 60,776 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 49 March 2026Restricted Stock Units · traded 5 March 2026 · filed 9 March 2026
- was granted 96,723 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 49 March 2026Stock Option (right to buy) · traded 5 March 2026 · filed 9 March 2026
- was granted 60,776 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 49 March 2026Restricted Stock Units · traded 5 March 2026 · filed 9 March 2026
- ▼ sold on the open market 5,443 shares of Tarsus PharmaceuticalsSEC Form 430 December 2025Common Stock · traded 24 December 2025 · filed 30 December 2025
- ▼ sold on the open market 557 shares of Tarsus PharmaceuticalsSEC Form 430 December 2025Common Stock · traded 24 December 2025 · filed 30 December 2025
- gave away 51,885 shares of Tarsus PharmaceuticalsSEC Form 48 December 2025Common Stock · traded 4 December 2025 · filed 8 December 2025
- ▼ sold on the open market 6,000 shares of Tarsus PharmaceuticalsSEC Form 426 September 2025Common Stock · traded 24 September 2025 · filed 26 September 2025
- ▼ sold on the open market 6,000 shares of Tarsus PharmaceuticalsSEC Form 413 August 2025Common Stock · traded 11 August 2025 · filed 13 August 2025
- ▼ sold on the open market 6,000 shares of Tarsus PharmaceuticalsSEC Form 426 March 2025Common Stock · traded 24 March 2025 · filed 26 March 2025
- ▼ sold on the open market 7,131 shares of Tarsus PharmaceuticalsSEC Form 420 March 2025Common Stock · traded 18 March 2025 · filed 20 March 2025
- ▼ sold on the open market 8,551 shares of Tarsus PharmaceuticalsSEC Form 420 March 2025Common Stock · traded 19 March 2025 · filed 20 March 2025
- ▼ sold on the open market 8,534 shares of Tarsus PharmaceuticalsSEC Form 420 March 2025Common Stock · traded 20 March 2025 · filed 20 March 2025
- exercised options over 11,299 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 418 March 2025Restricted Stock Units · traded 15 March 2025 · filed 18 March 2025
- exercised options over 16,975 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 418 March 2025Restricted Stock Units · traded 15 March 2025 · filed 18 March 2025
- exercised options over 23,121 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 418 March 2025Restricted Stock Units · traded 15 March 2025 · filed 18 March 2025
- exercised options over 51,395 shares of Tarsus PharmaceuticalsSEC Form 418 March 2025Common Stock · traded 15 March 2025 · filed 18 March 2025
- was granted 90,736 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 47 March 2025Stock Option (right to buy) · traded 5 March 2025 · filed 7 March 2025
- was granted 59,512 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 47 March 2025Restricted Stock Units · traded 5 March 2025 · filed 7 March 2025
- exercised options over 11,299 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 419 March 2024Restricted Stock Units · traded 15 March 2024 · filed 19 March 2024
- exercised options over 16,975 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 419 March 2024Restricted Stock Units · traded 15 March 2024 · filed 19 March 2024
- exercised options over 28,274 shares of Tarsus PharmaceuticalsSEC Form 419 March 2024Common Stock · traded 15 March 2024 · filed 19 March 2024
- ▼ sold on the open market 10,415 shares of Tarsus PharmaceuticalsSEC Form 419 March 2024Common Stock · traded 18 March 2024 · filed 19 March 2024
- was granted 136,947 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 411 March 2024Stock Option (right to buy) · traded 7 March 2024 · filed 11 March 2024
- was granted 92,485 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 411 March 2024Restricted Stock Units · traded 7 March 2024 · filed 11 March 2024
- ▼ sold on the open market 8,000 shares of Tarsus PharmaceuticalsSEC Form 429 December 2023Common Stock · traded 27 December 2023 · filed 29 December 2023
- ▼ sold on the open market 9,443 shares of Tarsus PharmaceuticalsSEC Form 422 December 2023Common Stock · traded 20 December 2023 · filed 22 December 2023
- ▼ sold on the open market 30,557 shares of Tarsus PharmaceuticalsSEC Form 422 December 2023Common Stock · traded 20 December 2023 · filed 22 December 2023
- ▼ sold on the open market 2,896 shares of Tarsus PharmaceuticalsSEC Form 417 November 2023Common Stock · traded 15 November 2023 · filed 17 November 2023
- ▼ sold on the open market 4,904 shares of Tarsus PharmaceuticalsSEC Form 417 November 2023Common Stock · traded 15 November 2023 · filed 17 November 2023
- ▼ sold on the open market 200 shares of Tarsus PharmaceuticalsSEC Form 417 November 2023Common Stock · traded 15 November 2023 · filed 17 November 2023
- ▼ sold on the open market 8,000 shares of Tarsus PharmaceuticalsSEC Form 420 October 2023Common Stock · traded 18 October 2023 · filed 20 October 2023
- ▼ sold on the open market 8,000 shares of Tarsus PharmaceuticalsSEC Form 422 September 2023Common Stock · traded 20 September 2023 · filed 22 September 2023
- ▼ sold on the open market 8,000 shares of Tarsus PharmaceuticalsSEC Form 425 August 2023Common Stock · traded 23 August 2023 · filed 25 August 2023
- ▼ sold on the open market 4,174 shares of Tarsus PharmaceuticalsSEC Form 421 July 2023Common Stock · traded 19 July 2023 · filed 21 July 2023
- ▼ sold on the open market 99,726 shares of Tarsus PharmaceuticalsSEC Form 421 July 2023Common Stock · traded 19 July 2023 · filed 21 July 2023
- ▼ sold on the open market 9,000 shares of Tarsus PharmaceuticalsSEC Form 414 July 2023Common Stock · traded 12 July 2023 · filed 14 July 2023
- ▼ sold on the open market 8,000 shares of Tarsus PharmaceuticalsSEC Form 423 June 2023Common Stock · traded 21 June 2023 · filed 23 June 2023
- ▼ sold on the open market 9,000 shares of Tarsus PharmaceuticalsSEC Form 416 June 2023Common Stock · traded 14 June 2023 · filed 16 June 2023
- ▼ sold on the open market 3,100 shares of Tarsus PharmaceuticalsSEC Form 412 June 2023Common Stock · traded 8 June 2023 · filed 12 June 2023
- ▼ sold on the open market 8,000 shares of Tarsus PharmaceuticalsSEC Form 419 May 2023Common Stock · traded 17 May 2023 · filed 19 May 2023
- ▼ sold on the open market 9,000 shares of Tarsus PharmaceuticalsSEC Form 412 May 2023Common Stock · traded 10 May 2023 · filed 12 May 2023
- ▼ sold on the open market 4,278 shares of Tarsus PharmaceuticalsSEC Form 42 May 2023Common Stock · traded 28 April 2023 · filed 2 May 2023
- ▼ sold on the open market 5,841 shares of Tarsus PharmaceuticalsSEC Form 42 May 2023Common Stock · traded 1 May 2023 · filed 2 May 2023
- ▼ sold on the open market 2,311 shares of Tarsus PharmaceuticalsSEC Form 425 April 2023Common Stock · traded 21 April 2023 · filed 25 April 2023
- ▼ sold on the open market 8,000 shares of Tarsus PharmaceuticalsSEC Form 421 April 2023Common Stock · traded 19 April 2023 · filed 21 April 2023
- ▼ sold on the open market 679 shares of Tarsus PharmaceuticalsSEC Form 423 March 2023Common Stock · traded 21 March 2023 · filed 23 March 2023
- ▼ sold on the open market 709 shares of Tarsus PharmaceuticalsSEC Form 423 March 2023Common Stock · traded 22 March 2023 · filed 23 March 2023
- ▼ sold on the open market 737 shares of Tarsus PharmaceuticalsSEC Form 423 March 2023Common Stock · traded 23 March 2023 · filed 23 March 2023
- ▼ sold on the open market 795 shares of Tarsus PharmaceuticalsSEC Form 421 March 2023Common Stock · traded 17 March 2023 · filed 21 March 2023
- ▼ sold on the open market 741 shares of Tarsus PharmaceuticalsSEC Form 421 March 2023Common Stock · traded 20 March 2023 · filed 21 March 2023
- exercised options over 11,299 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 417 March 2023Restricted Stock Units · traded 15 March 2023 · filed 17 March 2023
- ▼ sold on the open market 8,000 shares of Tarsus PharmaceuticalsSEC Form 417 March 2023Common Stock · traded 15 March 2023 · filed 17 March 2023
- exercised options over 11,299 shares of Tarsus PharmaceuticalsSEC Form 417 March 2023Common Stock · traded 15 March 2023 · filed 17 March 2023
- ▼ sold on the open market 791 shares of Tarsus PharmaceuticalsSEC Form 417 March 2023Common Stock · traded 16 March 2023 · filed 17 March 2023
- was granted 100,242 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 410 March 2023Stock Option (right to buy) · traded 8 March 2023 · filed 10 March 2023
- was granted 67,900 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 410 March 2023Restricted Stock Units · traded 8 March 2023 · filed 10 March 2023
- ▼ sold on the open market 4,853 shares of Tarsus PharmaceuticalsSEC Form 410 March 2023Common Stock · traded 8 March 2023 · filed 10 March 2023
- ▼ sold on the open market 717 shares of Tarsus PharmaceuticalsSEC Form 410 March 2023Common Stock · traded 9 March 2023 · filed 10 March 2023
- ▼ sold on the open market 8,000 shares of Tarsus PharmaceuticalsSEC Form 417 February 2023Common Stock · traded 15 February 2023 · filed 17 February 2023
- ▼ sold on the open market 9,000 shares of Tarsus PharmaceuticalsSEC Form 410 February 2023Common Stock · traded 8 February 2023 · filed 10 February 2023
- ▼ sold on the open market 4,856 shares of Tarsus PharmaceuticalsSEC Form 425 January 2023Common Stock · traded 23 January 2023 · filed 25 January 2023
- ▼ sold on the open market 411 shares of Tarsus PharmaceuticalsSEC Form 424 January 2023Common Stock · traded 6 January 2023 · filed 24 January 2023
- ▼ sold on the open market 8,000 shares of Tarsus PharmaceuticalsSEC Form 420 January 2023Common Stock · traded 18 January 2023 · filed 20 January 2023
- ▼ sold on the open market 240 shares of Tarsus PharmaceuticalsSEC Form 420 January 2023Common Stock · traded 20 January 2023 · filed 20 January 2023
- ▼ sold on the open market 3,904 shares of Tarsus PharmaceuticalsSEC Form 413 January 2023Common Stock · traded 11 January 2023 · filed 13 January 2023
- ▼ sold on the open market 729 shares of Tarsus PharmaceuticalsSEC Form 411 January 2023Common Stock · traded 9 January 2023 · filed 11 January 2023
- ▼ sold on the open market 905 shares of Tarsus PharmaceuticalsSEC Form 411 January 2023Common Stock · traded 10 January 2023 · filed 11 January 2023
- ▼ sold on the open market 8,000 shares of Tarsus PharmaceuticalsSEC Form 422 December 2022Common Stock · traded 21 December 2022 · filed 22 December 2022
- ▼ sold on the open market 535 shares of Tarsus PharmaceuticalsSEC Form 420 December 2022Common Stock · traded 16 December 2022 · filed 20 December 2022
- ▼ sold on the open market 6,420 shares of Tarsus PharmaceuticalsSEC Form 416 December 2022Common Stock · traded 14 December 2022 · filed 16 December 2022
- ▼ sold on the open market 7,255 shares of Tarsus PharmaceuticalsSEC Form 418 November 2022Common Stock · traded 16 November 2022 · filed 18 November 2022
- ▼ sold on the open market 745 shares of Tarsus PharmaceuticalsSEC Form 418 November 2022Common Stock · traded 16 November 2022 · filed 18 November 2022
- ▼ sold on the open market 9,000 shares of Tarsus PharmaceuticalsSEC Form 414 November 2022Common Stock · traded 9 November 2022 · filed 14 November 2022
- ▼ sold on the open market 7,900 shares of Tarsus PharmaceuticalsSEC Form 421 October 2022Common Stock · traded 19 October 2022 · filed 21 October 2022
- ▼ sold on the open market 100 shares of Tarsus PharmaceuticalsSEC Form 421 October 2022Common Stock · traded 19 October 2022 · filed 21 October 2022
- ▼ sold on the open market 6,179 shares of Tarsus PharmaceuticalsSEC Form 414 October 2022Common Stock · traded 12 October 2022 · filed 14 October 2022
- ▼ sold on the open market 2,821 shares of Tarsus PharmaceuticalsSEC Form 414 October 2022Common Stock · traded 12 October 2022 · filed 14 October 2022
- ▼ sold on the open market 7,900 shares of Tarsus PharmaceuticalsSEC Form 423 September 2022Common Stock · traded 21 September 2022 · filed 23 September 2022
- ▼ sold on the open market 100 shares of Tarsus PharmaceuticalsSEC Form 423 September 2022Common Stock · traded 21 September 2022 · filed 23 September 2022
- ▼ sold on the open market 9,000 shares of Tarsus PharmaceuticalsSEC Form 416 September 2022Common Stock · traded 14 September 2022 · filed 16 September 2022
- ▼ sold on the open market 7,264 shares of Tarsus PharmaceuticalsSEC Form 419 August 2022Common Stock · traded 17 August 2022 · filed 19 August 2022
- ▼ sold on the open market 736 shares of Tarsus PharmaceuticalsSEC Form 419 August 2022Common Stock · traded 17 August 2022 · filed 19 August 2022
- was granted 154,067 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 411 March 2022Stock Option (right to buy) · traded 9 March 2022 · filed 11 March 2022
- was granted 45,197 shares of Tarsus Pharmaceuticals (a derivative holding)SEC Form 411 March 2022Restricted Stock Units · traded 9 March 2022 · filed 11 March 2022
- ▼ sold on the open market 2,394 shares of Tarsus PharmaceuticalsSEC Form 43 December 2021Common Stock · traded 1 December 2021 · filed 3 December 2021
- ▼ sold on the open market 2,101 shares of Tarsus PharmaceuticalsSEC Form 43 December 2021Common Stock · traded 1 December 2021 · filed 3 December 2021
- ▼ sold on the open market 760 shares of Tarsus PharmaceuticalsSEC Form 43 December 2021Common Stock · traded 1 December 2021 · filed 3 December 2021
- ▼ sold on the open market 578 shares of Tarsus PharmaceuticalsSEC Form 43 December 2021Common Stock · traded 1 December 2021 · filed 3 December 2021
- ▼ sold on the open market 5,033 shares of Tarsus PharmaceuticalsSEC Form 43 November 2021Common Stock · traded 1 November 2021 · filed 3 November 2021
- ▼ sold on the open market 800 shares of Tarsus PharmaceuticalsSEC Form 43 November 2021Common Stock · traded 1 November 2021 · filed 3 November 2021
- ▼ sold on the open market 833 shares of Tarsus PharmaceuticalsSEC Form 414 October 2021Common Stock · traded 12 October 2021 · filed 14 October 2021
- ▼ sold on the open market 4,698 shares of Tarsus PharmaceuticalsSEC Form 414 October 2021Common Stock · traded 12 October 2021 · filed 14 October 2021
- ▼ sold on the open market 302 shares of Tarsus PharmaceuticalsSEC Form 412 October 2021Common Stock · traded 8 October 2021 · filed 12 October 2021
- ▼ sold on the open market 5,733 shares of Tarsus PharmaceuticalsSEC Form 43 September 2021Common Stock · traded 1 September 2021 · filed 3 September 2021
- ▼ sold on the open market 100 shares of Tarsus PharmaceuticalsSEC Form 43 September 2021Common Stock · traded 1 September 2021 · filed 3 September 2021
- ▼ sold on the open market 103 shares of Tarsus PharmaceuticalsSEC Form 412 August 2021Common Stock · traded 10 August 2021 · filed 12 August 2021
- ▼ sold on the open market 1,917 shares of Tarsus PharmaceuticalsSEC Form 412 August 2021Common Stock · traded 11 August 2021 · filed 12 August 2021
- ▼ sold on the open market 1,616 shares of Tarsus PharmaceuticalsSEC Form 410 August 2021Common Stock · traded 6 August 2021 · filed 10 August 2021
- ▼ sold on the open market 727 shares of Tarsus PharmaceuticalsSEC Form 410 August 2021Common Stock · traded 9 August 2021 · filed 10 August 2021
- ▼ sold on the open market 100 shares of Tarsus PharmaceuticalsSEC Form 410 August 2021Common Stock · traded 9 August 2021 · filed 10 August 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.